Cargando…

Reciprocal interferences of the left ventricular assist device and the aortic valve competence

Patients suffering from end-stage heart failure tend to have high mortality rates. With growing numbers of patients progressing into severe heart failure, the shortage of available donors is a growing concern, with less than 10% of patients undergoing cardiac transplantation (CTx). Fortunately, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Vriz, Olga, Mushtaq, Ali, Shaik, Abdullah, El-Shaer, Ahmed, Feras, Khalid, Eltayeb, Abdalla, Alsergnai, Hani, Kholaif, Naji, Al Hussein, Mosaad, Albert-Brotons, Dimpna, Simon, Andre Rudiger, Tsai, Felix Wang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870593/
https://www.ncbi.nlm.nih.gov/pubmed/36698950
http://dx.doi.org/10.3389/fcvm.2022.1094796
_version_ 1784877005218512896
author Vriz, Olga
Mushtaq, Ali
Shaik, Abdullah
El-Shaer, Ahmed
Feras, Khalid
Eltayeb, Abdalla
Alsergnai, Hani
Kholaif, Naji
Al Hussein, Mosaad
Albert-Brotons, Dimpna
Simon, Andre Rudiger
Tsai, Felix Wang
author_facet Vriz, Olga
Mushtaq, Ali
Shaik, Abdullah
El-Shaer, Ahmed
Feras, Khalid
Eltayeb, Abdalla
Alsergnai, Hani
Kholaif, Naji
Al Hussein, Mosaad
Albert-Brotons, Dimpna
Simon, Andre Rudiger
Tsai, Felix Wang
author_sort Vriz, Olga
collection PubMed
description Patients suffering from end-stage heart failure tend to have high mortality rates. With growing numbers of patients progressing into severe heart failure, the shortage of available donors is a growing concern, with less than 10% of patients undergoing cardiac transplantation (CTx). Fortunately, the use of left ventricular assist devices (LVADs), a variant of mechanical circulatory support has been on the rise in recent years. The expansion of LVADs has led them to be incorporated into a variety of clinical settings, based on the goals of therapy for patients ailing from heart failure. However, with an increase in the use of LVADs, there are a host of complications that arise with it. One such complication is the development and progression of aortic regurgitation (AR) which is noted to adversely influence patient outcomes and compromise pump benefits leading to increased morbidity and mortality. The underlying mechanisms are likely multifactorial and involve the aortic root-aortic valve (AV) complex, as well as the LVAD device, patient, and other factors, all of them alter the physiological mechanics of the heart resulting in AV dysfunction. Thus, it is imperative to screen patients before LVAD implantation for AR, as moderate or greater AR requires a concurrent intervention at the time of LVADs implantation. No current strict guidelines were identified in the literature search on how to actively manage and limit the development and/or progression of AR, due to the limited information. However, some recommendations include medical management by targeting fluid overload and arterial blood pressure, along with adjusting the settings of the LVADs device itself. Surgical interventions are to be considered depending on patient factors, goals of care, and the underlying pathology. These interventions include the closure of the AV, replacement of the valve, and percutaneous approach via percutaneous occluding device or transcatheter aortic valve implantation. In the present review, we describe the interaction between AV and LVAD placement, in terms of patient management and prognosis. Also it is provided a comprehensive echocardiographic strategy for the precise assessment of AV regurgitation severity.
format Online
Article
Text
id pubmed-9870593
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98705932023-01-24 Reciprocal interferences of the left ventricular assist device and the aortic valve competence Vriz, Olga Mushtaq, Ali Shaik, Abdullah El-Shaer, Ahmed Feras, Khalid Eltayeb, Abdalla Alsergnai, Hani Kholaif, Naji Al Hussein, Mosaad Albert-Brotons, Dimpna Simon, Andre Rudiger Tsai, Felix Wang Front Cardiovasc Med Cardiovascular Medicine Patients suffering from end-stage heart failure tend to have high mortality rates. With growing numbers of patients progressing into severe heart failure, the shortage of available donors is a growing concern, with less than 10% of patients undergoing cardiac transplantation (CTx). Fortunately, the use of left ventricular assist devices (LVADs), a variant of mechanical circulatory support has been on the rise in recent years. The expansion of LVADs has led them to be incorporated into a variety of clinical settings, based on the goals of therapy for patients ailing from heart failure. However, with an increase in the use of LVADs, there are a host of complications that arise with it. One such complication is the development and progression of aortic regurgitation (AR) which is noted to adversely influence patient outcomes and compromise pump benefits leading to increased morbidity and mortality. The underlying mechanisms are likely multifactorial and involve the aortic root-aortic valve (AV) complex, as well as the LVAD device, patient, and other factors, all of them alter the physiological mechanics of the heart resulting in AV dysfunction. Thus, it is imperative to screen patients before LVAD implantation for AR, as moderate or greater AR requires a concurrent intervention at the time of LVADs implantation. No current strict guidelines were identified in the literature search on how to actively manage and limit the development and/or progression of AR, due to the limited information. However, some recommendations include medical management by targeting fluid overload and arterial blood pressure, along with adjusting the settings of the LVADs device itself. Surgical interventions are to be considered depending on patient factors, goals of care, and the underlying pathology. These interventions include the closure of the AV, replacement of the valve, and percutaneous approach via percutaneous occluding device or transcatheter aortic valve implantation. In the present review, we describe the interaction between AV and LVAD placement, in terms of patient management and prognosis. Also it is provided a comprehensive echocardiographic strategy for the precise assessment of AV regurgitation severity. Frontiers Media S.A. 2023-01-09 /pmc/articles/PMC9870593/ /pubmed/36698950 http://dx.doi.org/10.3389/fcvm.2022.1094796 Text en Copyright © 2023 Vriz, Mushtaq, Shaik, El-Shaer, Feras, Eltayeb, Alsergnai, Kholaif, Al Hussein, Albert-Brotons, Simon and Tsai. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Vriz, Olga
Mushtaq, Ali
Shaik, Abdullah
El-Shaer, Ahmed
Feras, Khalid
Eltayeb, Abdalla
Alsergnai, Hani
Kholaif, Naji
Al Hussein, Mosaad
Albert-Brotons, Dimpna
Simon, Andre Rudiger
Tsai, Felix Wang
Reciprocal interferences of the left ventricular assist device and the aortic valve competence
title Reciprocal interferences of the left ventricular assist device and the aortic valve competence
title_full Reciprocal interferences of the left ventricular assist device and the aortic valve competence
title_fullStr Reciprocal interferences of the left ventricular assist device and the aortic valve competence
title_full_unstemmed Reciprocal interferences of the left ventricular assist device and the aortic valve competence
title_short Reciprocal interferences of the left ventricular assist device and the aortic valve competence
title_sort reciprocal interferences of the left ventricular assist device and the aortic valve competence
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870593/
https://www.ncbi.nlm.nih.gov/pubmed/36698950
http://dx.doi.org/10.3389/fcvm.2022.1094796
work_keys_str_mv AT vrizolga reciprocalinterferencesoftheleftventricularassistdeviceandtheaorticvalvecompetence
AT mushtaqali reciprocalinterferencesoftheleftventricularassistdeviceandtheaorticvalvecompetence
AT shaikabdullah reciprocalinterferencesoftheleftventricularassistdeviceandtheaorticvalvecompetence
AT elshaerahmed reciprocalinterferencesoftheleftventricularassistdeviceandtheaorticvalvecompetence
AT feraskhalid reciprocalinterferencesoftheleftventricularassistdeviceandtheaorticvalvecompetence
AT eltayebabdalla reciprocalinterferencesoftheleftventricularassistdeviceandtheaorticvalvecompetence
AT alsergnaihani reciprocalinterferencesoftheleftventricularassistdeviceandtheaorticvalvecompetence
AT kholaifnaji reciprocalinterferencesoftheleftventricularassistdeviceandtheaorticvalvecompetence
AT alhusseinmosaad reciprocalinterferencesoftheleftventricularassistdeviceandtheaorticvalvecompetence
AT albertbrotonsdimpna reciprocalinterferencesoftheleftventricularassistdeviceandtheaorticvalvecompetence
AT simonandrerudiger reciprocalinterferencesoftheleftventricularassistdeviceandtheaorticvalvecompetence
AT tsaifelixwang reciprocalinterferencesoftheleftventricularassistdeviceandtheaorticvalvecompetence